Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets

Figure 4

Mutation frequency in MSK-IMPACT cohorts. KRAS G12D (a), KRAS G12V (b), PIK3CA E545K (c), and PIK3CA H1047R (d) in MSK-IMPACT pan-cancer cohorts.

(a)

(b)

(c)

(d)